Lifevantage Corp (LFVN)

↓ Download CSV

CIK 0000849146 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Jun 30

In fiscal 2025, Lifevantage Corp reported revenue of $228.53M, up 14.2% from the prior year. The company was profitable, with a net margin of 4.3% and a gross margin of 80.4%. It held $71.96M in total assets against $37.32M in total liabilities.

Key ratios (FY2025)

80.4%
Gross margin
5.3%
Operating margin
4.3%
Net margin
28.3%
Return on equity
+14.2%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$228.53M$200.16M$213.40M$206.36M$220.18M$232.91M$225.96M$203.20M$199.49M
Cost of Revenue$44.86M$41.44M$43.39M$38.10M$38.19M$37.96M$37.97M$34.85M$33.46M$33.93M
Gross Profit$183.67M$158.72M$170.01M$168.26M$181.99M$194.95M$187.99M$168.36M$166.03M$172.61M
Operating Income$12.20M$4.33M$4.26M$7.58M$17.61M$15.47M$9.81M$10.32M$4.45M$13.41M
Net Income$9.80M$2.94M$2.54M$3.12M$12.89M$11.55M$7.43M$5.76M$1.61M$6.11M
EPS (Diluted)$0.75$0.23$0.20$0.24$0.90$0.79$0.50$0.41$0.11$0.42
Total Assets$71.96M$60.30M$66.12M$70.71M$78.73M$58.88M$55.27M$51.14M$45.25M$50.85M
Total Liabilities$37.32M$34.31M$31.47M$39.19M$41.92M$25.62M$28.07M$29.20M$30.72M$40.21M
Shareholders' Equity$34.64M$25.99M$34.65M$31.52M$36.81M$33.25M$27.20M$21.94M$14.53M$10.65M
Cash & Equivalents$20.20M$16.89M$21.61M$20.19M$23.17M$22.14M$18.82M$16.65M$11.46M$7.88M
Operating Cash Flow$11.88M$12.20M$6.83M$7.96M$16.27M$18.33M$17.79M$13.26M$6.60M$6.04M
Capital Expenditures$1.37M$2.25M$3.07M$1.53M$3.74M$2.68M$2.51M$4.65M$1.05M$562.0K
Shares Outstanding12.43M12.51M12.62M12.49M13.61M14.31M14.11M14.07M14.23M14.03M
Dividends Per Share$0.17$0.55$0.12$0.03